top-line results

July 7, 2020July 7, 2020

Bedtime Fibromyalgia Therapy TNX-102 SL Sees Faster-than-expected Trial Enrollment

News

Enrollment in the RELIEF Phase 3 trial assessing TNX-102 SL (sublingual cyclobenzaprine) as a nighttime treatment for pain and disturbed sleep due to fibromyalgia has been faster than expected, according ... Read more

June 12, 2019June 12, 2019

NYX-2925 Continues to Significantly Reduce Pain Severity Marker in Phase 2 Trial, Top Line Data Shows

News

Aptinyx’s NYX-2925 treatment candidate continues to significantly reduce the levels of a brain biomarker associated with pain severity, called glutamine (Glx), in people with fibromyalgia, top line results of a ... Read more